As of 2026-03-19, the EV/EBITDA ratio of Outset Medical Inc (OM) is -1.97. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OM's latest enterprise value is 122.57 mil USD. OM's TTM EBITDA according to its financial statements is -62.37 mil USD. Dividing these 2 quantities gives us the above OM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.8x - 14.2x | 12.3x |
| Forward P/E multiples | 15.6x - 17.9x | 15.9x |
| Fair Price | (56.55) - (51.64) | (51.37) |
| Upside | -1788.0% - -1641.6% | -1633.4% |
| Date | EV/EBITDA |
| 2026-03-17 | -2.04 |
| 2026-03-16 | -1.97 |
| 2026-03-13 | -1.94 |
| 2026-03-12 | -1.91 |
| 2026-03-11 | -1.94 |
| 2026-03-10 | -1.92 |
| 2026-03-09 | -1.93 |
| 2026-03-06 | -1.92 |
| 2026-03-05 | -1.99 |
| 2026-03-04 | -2.02 |
| 2026-03-03 | -2.00 |
| 2026-03-02 | -2.03 |
| 2026-02-27 | -2.01 |
| 2026-02-26 | -2.05 |
| 2026-02-25 | -1.97 |
| 2026-02-24 | -1.96 |
| 2026-02-23 | -1.97 |
| 2026-02-20 | -2.02 |
| 2026-02-19 | -2.02 |
| 2026-02-18 | -2.00 |
| 2026-02-17 | -1.94 |
| 2026-02-13 | -1.98 |
| 2026-02-12 | -2.10 |
| 2026-02-11 | -2.31 |
| 2026-02-10 | -2.36 |
| 2026-02-09 | -2.35 |
| 2026-02-06 | -2.30 |
| 2026-02-05 | -2.27 |
| 2026-02-04 | -2.42 |
| 2026-02-03 | -2.46 |
| 2026-02-02 | -2.44 |
| 2026-01-30 | -2.45 |
| 2026-01-29 | -2.47 |
| 2026-01-28 | -2.46 |
| 2026-01-27 | -2.65 |
| 2026-01-26 | -2.44 |
| 2026-01-23 | -2.48 |
| 2026-01-22 | -2.57 |
| 2026-01-21 | -2.51 |
| 2026-01-20 | -2.46 |
| 2026-01-16 | -2.54 |
| 2026-01-15 | -2.53 |
| 2026-01-14 | -2.59 |
| 2026-01-13 | -2.49 |
| 2026-01-12 | -2.62 |
| 2026-01-09 | -2.32 |
| 2026-01-08 | -2.35 |
| 2026-01-07 | -2.26 |
| 2026-01-06 | -2.24 |
| 2026-01-05 | -2.10 |